TV.QIAGENBIOINFORMATICS.COM
Cancer Drug Discovery
Exploring drug response in low-grade glioma
This webinar introduces the Tumor Microenvironment (TME) Pathway in QIAGEN’s Ingenuity...
QIAGEN IPA
Somatic variants investigation in critical regulatory pathways
This training will focus on using QIAGEN Ingenuity Pathway analysis (IPA) and Human...
QIAGEN IPA
IPA Deeper Dive: miRNA investigation using IPA
In this 90-minute training session, you will learn how to identify target mRNAs for...
QIAGEN CLC Genomics
RNA-seq data analysis and interpretation with QIAGEN CLC Genomics Workbench...
In this 90-minute training, users will learn how to easily analyze and interpret...
QCI Interpret for Oncology
FASTQ to final report: Ultra-fast workflow for CGP
As our molecular knowledge of cancer continually evolves, a new era in cancer care is...
QIAGEN OmicSoft and Biomedical Knowledge Base
Knowledge graphs and more: Analytics-driven drug discovery using advanced...
High-quality biomedical relationships knowledge is the cornerstone of modern and...
QCI Interpret for Oncology
50 to 500 genes: Scale-up to comprehensive genomic profiling
In this webinar, we present a workflow-agnostic, informatics software solution that...
QIAGEN IPA
Drug repurposing: from large-scale biological data to therapeutics
One of the challenges we are facing today is the high cost and slow pace of drug...
QIAGEN CLC Genomics
Single-cell RNA-seq data analysis and Interpretation
Slides from this training: https://qiagen.showpad.com/share/WAXz1vrHBsvArdeceWpcX In...
Clinical Summits
Break the data bottleneck summit: Precision Oncology Expert Panel in Americas
Lower the Barrier to Adopt Large Cancer Genomic Profiling in Diagnostic Labs: Break the...
Discovery and Research User Group Meetings +
Virtual Roundtable: Data Curation and AI/Machine Learning in Drug Discovery...
Pharmaceutical companies and researchers are increasingly turning to artificial...
Clinical Summits
Break the data bottleneck summit: Precision Oncology Expert Panel in Europe
Lower the Barrier to Adopt Large Cancer Genomic Profiling in Diagnostic Labs: Break the...